Nitric Oxide: The Forgotten Child of Tumor Metabolism

Bahar Salimian Rizi1, Abhinav Achreja2, Deepak Nagrath3

  • 1Agilent Technologies, Lexington, Massachusetts, USA; These authors contributed equally to this work.

Trends in Cancer
|September 5, 2017
PubMed

Insights

Nitric oxide (NO) plays dual roles in cancer, influencing tumor growth and patient outcomes. Targeting NO metabolism alongside standard therapies may improve cancer treatment effectiveness.

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Background:

  • Nitric oxide (NO) is a crucial signaling molecule with diverse physiological functions.
  • In cancer, NO exhibits both tumor-promoting and tumor-suppressing roles, impacting neoplasticity, invasiveness, and chemoresistance.

Purpose of the Study:

  • To review the intricate mechanisms linking nitric oxide to cancer hallmarks.
  • To explore the potential of co-targeting NO metabolism with existing cancer therapies for enhanced patient outcomes.

Main Methods:

  • Literature review of studies investigating nitric oxide's role in cancer.
  • Analysis of NO's impact on cancer cell metabolism, immune evasion, and angiogenesis.
  • Discussion of NO's regulatory effects on protein modifications and epigenetic alterations.

Main Results:

  • NO synthesis and signaling are associated with key cancer characteristics, including altered metabolism, invasiveness, and immune evasion.
  • Exogenous NO influences the tumor microenvironment, affecting paracrine signaling, immune responses, and angiogenesis.
  • NO-mediated posttranslational modifications (e.g., S-nitrosation) and epigenetic changes can exert both tumor-promoting and tumor-suppressing effects.

Conclusions:

  • Understanding the complex roles of NO in cancer is critical for developing novel therapeutic strategies.
  • Co-targeting NO metabolism with first-line cancer therapies presents a promising avenue for improving treatment outcomes.
  • Quantitative flux analysis is essential for a comprehensive study of NO dynamics within tumors.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Overview of Nitrogen Metabolism01:20

Overview of Nitrogen Metabolism

Nitrogen is a very important element for life because it is a major constituent of proteins and nucleic acids. It is a macronutrient, and in nature, it is recycled from organic compounds and stored in the form of  ammonia, ammonium ions, nitrate, nitrite, or  nitrogen gas by many metabolic processes. Many of these metabolic processes are carried out only by prokaryotes.
The largest pool of nitrogen available in the terrestrial ecosystem is gaseous nitrogen (N2) from the air, but this...
11.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K